Median Technologies

ALMDT

Company Profile

  • Business description

    Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.

  • Contact

    1800 Route Des Cretes
    Les Deux Arcs B
    Valbonne06560
    FRA

    T: +33 493333777

    https://www.mediantechnologies.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    153

Stocks News & Analysis

stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

With the monetization of GenAI, here’s what we think of Alphabet’s stock
stocks

Going into earnings, Is Meta stock a buy, a sell, or fairly valued?

With a focus on leveraging its AI investments, here’s what we think of Meta stock.
stocks

Our view of BHP after June quarter results

Record copper volumes are reported.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,926.2080.60-0.89%
CAC 407,798.2224.45-0.31%
DAX 4024,307.8018.290.08%
Dow JONES (US)44,323.0719.12-0.04%
FTSE 1009,012.9920.870.23%
HKSE24,994.14168.480.68%
NASDAQ20,974.1878.520.38%
Nikkei 22539,819.1182.08-0.21%
NZX 50 Index12,961.5181.110.63%
S&P 5006,305.608.810.14%
S&P/ASX 2008,668.2089.00-1.02%
SSE Composite Index3,559.7925.310.72%

Market Movers